Pfizer, BioNTech Submit COVID Vaccine Data To FDA For Kids 5-11

Pfizer and BioNTech have submitted data to the FDA from trials of nearly 2300 participants aged 5-11.

Dr. Anthony Fauci suggests pending FDA approval, children will be eligible for COVID vaccines by the end of October.

What can we expect next for the fourth quarter? Listen to Ebony McMorris’ report.

Click to listen to Ebony McMorris’s AURN News report:

It’s official: We have submitted initial data from the pivotal trial of our COVID-19 vaccine in children 5 to under 12 years of age to the @US_FDA: https://t.co/XORlEFksAs

— AlbertBourla (@AlbertBourla) September 28, 2021

The post Pfizer, BioNTech Submit COVID Vaccine Data To FDA For Kids 5-11 appeared first on American Urban Radio Networks.